Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
Elli Papaemmanuil(Memorial Sloan Kettering Cancer Center), Peter J. Campbell(Wellcome Sanger Institute), Keiran Raine(Wellcome Sanger Institute), Chris McGee(Wellcome Sanger Institute), David Jones(European Bioinformatics Institute), Inmaculada Rapado(Wellcome Sanger Institute), Anna L. Godfrey(University of Namur), Alan J. Warren(Wellcome/MRC Cambridge Stem Cell Institute), Erica Travaglino(Policlinico San Matteo Fondazione), Ana Cvejic(University of Copenhagen), Nicholas C.P. Cross(University of Southampton), Carlo Gambacorti‐Passerini(Azienda Ospedaliera San Gerardo), Anna Gallì(University of Pavia), Jacqueline Boultwood(University of Oxford), Kristina Anderson(Harvard University Press), Patrick Tarpey(Wellcome Sanger Institute), Nikhil C. Munshi(Dana-Farber Cancer Institute), E. Joanna Baxter(University of Cambridge), Anthony R. Green(Wellcome/MRC Cambridge Stem Cell Institute), Mario Cazzola(Roche (Switzerland)), Richard Rance(Wellcome Sanger Institute), Peter Ellis(Oldham Council), Michael R. Stratton(Wellcome Sanger Institute), Ignacio Varela(Wellcome Sanger Institute), Adam Shlien(Hospital for Sick Children), Michael J. Groves(Lingnan University), Ville Mustonen(Wellcome Sanger Institute), Laura Mudie(Wellcome Sanger Institute), Andrej Fischer(University of Cologne), Charles Massie(University of Cambridge), P. Andrew Futreal(Wellcome Sanger Institute), Luca Malcovati(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Serena Nik‐Zainal(University of Cambridge), Paresh Vyas(University of Oxford), Helen Davies(German Cancer Research Center), Adel K. El‐Naggar(Barking, Havering And Redbridge University Hospitals NHS Trust), Jonathan Hinton(Wellcome Sanger Institute), Sudhir Tauro(University of Dundee), Matteo Giovanni Della Porta(Humanitas University), Eva Hellström‐Lindberg(Karolinska Institutet), Stuart McLaren(European Bioinformatics Institute), Jon W. Teague(Wellcome Sanger Institute), J Score(International Breast Cancer Study Group), James S. Wainscoat(University of Oxford), Adam P. Butler(Wellcome Sanger Institute), Andrea Pellagatti(University of Oxford), Philip J. Stephens(United States Department of the Navy), David Bowen(University of Tennessee Health Science Center)
Cited by 1,214
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
COSMIC: the Catalogue Of Somatic Mutations In Cancer
|Nucleic Acids Research|2018|5.2k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k